Australien - engelska - Department of Health (Therapeutic Goods Administration)

alembic pharmaceuticals australia pty ltd - aripiprazole, quantity: 5 mg - tablet, uncoated - excipient ingredients: maize starch; crospovidone; indigo carmine aluminium lake; hyprolose; magnesium stearate; microcrystalline cellulose; silicon dioxide; lactose monohydrate - alembic aripiprazole is indicated for the treatment of schizophrenia including maintenance of clinical improvement during continuation therapy.,acute treatment of manic or mixed episodes associated with bipolar i disorder in adults as monotherapy and in combination with lithium or valproate;,maintenance treatment of manic or mixed episodes in bipolar i disorder in adults as monotherapy.

Australien - engelska - Department of Health (Therapeutic Goods Administration)

alembic pharmaceuticals australia pty ltd - lacosamide, quantity: 150 mg - tablet, film coated - excipient ingredients: magnesium stearate; crospovidone; hyprolose; colloidal anhydrous silica; microcrystalline cellulose; titanium dioxide; hypromellose; purified talc; iron oxide yellow; macrogol 6000; iron oxide red; iron oxide black; macrogol 400 - alembic lacosamide (lacosamide) tablets are indicated as: ? monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 16 years and older. ? add-on therapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 4 years and older. ? add-on therapy in the treatment of primary generalised tonic-clonic seizures in patients with idiopathic generalised epilepsy aged 4 years and older.

Australien - engelska - Department of Health (Therapeutic Goods Administration)

alembic pharmaceuticals australia pty ltd - lacosamide, quantity: 200 mg - tablet, film coated - excipient ingredients: colloidal anhydrous silica; crospovidone; magnesium stearate; hyprolose; microcrystalline cellulose; titanium dioxide; hypromellose; purified talc; macrogol 6000; macrogol 400; indigo carmine aluminium lake - alembic lacosamide (lacosamide) tablets are indicated as: ? monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 16 years and older. ? add-on therapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 4 years and older. ? add-on therapy in the treatment of primary generalised tonic-clonic seizures in patients with idiopathic generalised epilepsy aged 4 years and older.

Australien - engelska - Department of Health (Therapeutic Goods Administration)

alembic pharmaceuticals australia pty ltd - lacosamide, quantity: 50 mg - tablet, film coated - excipient ingredients: crospovidone; hyprolose; magnesium stearate; colloidal anhydrous silica; microcrystalline cellulose; titanium dioxide; hypromellose; purified talc; macrogol 6000; iron oxide red; iron oxide black; macrogol 400; indigo carmine aluminium lake - alembic lacosamide (lacosamide) tablets are indicated as: ? monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 16 years and older. ? add-on therapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 4 years and older. ? add-on therapy in the treatment of primary generalised tonic-clonic seizures in patients with idiopathic generalised epilepsy aged 4 years and older.

Australien - engelska - Department of Health (Therapeutic Goods Administration)

alembic pharmaceuticals australia pty ltd - lacosamide, quantity: 100 mg - tablet, film coated - excipient ingredients: magnesium stearate; colloidal anhydrous silica; microcrystalline cellulose; crospovidone; hyprolose; titanium dioxide; hypromellose; purified talc; iron oxide yellow; macrogol 6000; macrogol 400 - alembic lacosamide (lacosamide) tablets are indicated as: ? monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 16 years and older. ? add-on therapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 4 years and older. ? add-on therapy in the treatment of primary generalised tonic-clonic seizures in patients with idiopathic generalised epilepsy aged 4 years and older.

Australien - engelska - Department of Health (Therapeutic Goods Administration)

alembic pharmaceuticals australia pty ltd - lurasidone hydrochloride, quantity: 80 mg - tablet, film coated - excipient ingredients: hypromellose; maize starch; mannitol; croscarmellose sodium; magnesium stearate; titanium dioxide; macrogol 8000; iron oxide yellow; indigo carmine aluminium lake - alembic lurasidone is indicated for the treatment of schizophrenia in adults and adolescents (aged 13 to 17 years).

Australien - engelska - Department of Health (Therapeutic Goods Administration)

alembic pharmaceuticals australia pty ltd - lurasidone hydrochloride, quantity: 40 mg - tablet, film coated - excipient ingredients: hypromellose; maize starch; mannitol; croscarmellose sodium; magnesium stearate; titanium dioxide; macrogol 8000 - alembic lurasidone is indicated for the treatment of schizophrenia in adults and adolescents (aged 13 to 17 years).

Australien - engelska - Department of Health (Therapeutic Goods Administration)

alembic pharmaceuticals australia pty ltd - lurasidone hydrochloride, quantity: 20 mg - tablet, film coated - excipient ingredients: hypromellose; maize starch; mannitol; croscarmellose sodium; magnesium stearate; titanium dioxide; macrogol 8000 - alembic lurasidone is indicated for the treatment of schizophrenia in adults and adolescents (aged 13 to 17 years).

Australien - engelska - Department of Health (Therapeutic Goods Administration)

alembic pharmaceuticals australia pty ltd - deferasirox, quantity: 180 mg - tablet, film coated - excipient ingredients: crospovidone; microcrystalline cellulose; poloxamer; magnesium stearate; colloidal anhydrous silica; sodium starch glycollate type a; povidone; titanium dioxide; indigo carmine aluminium lake; hypromellose; purified talc; macrogol 4000 - the treatment of chronic iron overload due to blood transfusions (transfusional haemosiderosis) in adults and paediatric patients 6 years and older. chealembic is also indicated for the treatment of chronic iron overload in paediatric patients aged 2 to 5 years who are unable to take desferrioxamine therapy or in whom desferrioxamine has proven ineffective. ,chealembic is also indicated for the treatment of chronic iron overload in patients with non-transfusion- dependent thalassemia syndromes aged 10 years and older.

Australien - engelska - Department of Health (Therapeutic Goods Administration)

alembic pharmaceuticals australia pty ltd - deferasirox, quantity: 360 mg - tablet, film coated - excipient ingredients: povidone; magnesium stearate; colloidal anhydrous silica; poloxamer; sodium starch glycollate type a; microcrystalline cellulose; crospovidone; titanium dioxide; hypromellose; indigo carmine aluminium lake; purified talc; macrogol 4000 - the treatment of chronic iron overload due to blood transfusions (transfusional haemosiderosis) in adults and paediatric patients 6 years and older. chealembic is also indicated for the treatment of chronic iron overload in paediatric patients aged 2 to 5 years who are unable to take desferrioxamine therapy or in whom desferrioxamine has proven ineffective.,chealembic is also indicated for the treatment of chronic iron overload in patients with non-transfusion- dependent thalassemia syndromes aged 10 years and older.